Dynamic quotes: Off
|
Company Description (as filed with the SEC)
We are an integrated, global healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. In 2012, our net sales amounted to €34,947 million. We are the fourth largest pharmaceutical group in the world and the third largest pharmaceutical group in Europe (source: IMS sales 2012). Sanofi is the parent of a consolidated group of companies. A list of the principal subsidiaries included in this consolidation is shown at Note F. to our consolidated financial statements included at Item 18 of this annual report. The Sanofi Group is organized around three principal activities: Pharmaceuticals, Human Vaccines via Sanofi Pasteur, and Animal Health via Merial Limited (Merial). These activities are operating segments within the meaning of the IFRS 8 accounting standard (see Note D.35. to the consolidated financial statements). ... More ...
Analyst Info |
|
| Annual EPS Est: | |
| Quarterly EPS Est: | |
| PEG Ratio: | |
|
Mean Recommendation: View Summary / View All |
|
Data is provided by Zacks Investment Research
